USTR Launches Probe Into German Pharma Costs
The U.S. Trade Representative has opened an investigation into whether Germany has been underpaying for certain pharmaceutical products in a way that burdens U.S. consumers with added costs, which could lead...To view the full article, register now.
Already a subscriber? Click here to view full article